相关实验视频

Updated: Jun 28, 2025

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues

Published on: June 3, 2019

在肥胖的高血压小鼠中,Resolvin D2通过调节血管和促炎因素,防止血管重塑,超收缩性和内皮功能障碍

Raquel Rodrigues-Diez¹, Constanza Ballesteros-Martinez², Rosa María Moreno-Carriles³

¹Departamento de Farmacología, Facultad de Medicina, Universidad Autónoma de Madrid. Instituto de Investigación Hospital Universitario La Paz (IdiPaz), Madrid, Spain; CIBER de Enfermedades Cardiovasculares, Spain; Departamento de Fisiología, Facultad de Medicina, Universidad Complutense de Madrid, Spain.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|April 12, 2024

概括

通过减少炎症和改善细胞功能,Resolvin D2 (RvD2) 可以预防肥胖和高血压的血管损伤. 这种专门的前期调解媒介在保护病理性血管改造方面表现有前途.

科学领域:

心血管研究研究心血管研究
炎症生物学炎症生物学
药理学药理学是指药理学的学科.

背景情况:

专门的预溶解调解剂 (SPMs),包括溶解素,对于解决炎症和恢复组织平衡至关重要.
SPM通路的调节失调可能会导致肥胖和高血压等疾病的病态血管重塑.

研究的目的:

调查Rolvin D2 (RvD2) 在预防与肥胖和高血压相关的血管改造和功能障碍方面的作用.
在实验模型和人体样本中评估RvD2对血管和免疫细胞的影响.

主要方法:

从患有和没有腹腔大动脉动脉瘤 (AAA) 的患者的大动脉样本中分析基因表达 (ALOXs,SPMs受体,促炎基因).
在小鼠中使用高脂肪饮食 (HFD) 和血管新素II (AngII) 输液进行大动脉扩张的实验模型,并给予RvD2.
对血管结构,功能,炎症标志物和巨细胞因应AngII和RvD的反应进行评估2.

主要成果:

在患者中发现AAA,肥胖和ALOX15,GPR18和促炎基因的表达之间的积极相关性.
在小鼠模型中,RvD2部分预防了肥胖,脂肪组织炎症,高血压,血管重塑,超收缩性,内皮功能障碍和亡.
RvD2 改善了巨细胞增生,并调节了对 AngII.II 的反应中 SPM 概况.

结论:

RvD2可能代表了一种新的治疗策略,用于预防与高血压和肥胖有关的血管损伤.
RvD2对血管和免疫细胞产生保护作用,减轻炎症和功能障碍.

关键词:

内皮质功能障碍内皮质功能障碍在高血压的高血压.肥胖问题肥胖问题炎症的解消炎症的解消在Resolvin D2中使用Resolvin D2.血管改造血管改造血管改造

更多相关视频

Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy

Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy

Published on: September 29, 2017

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Published on: December 5, 2017

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Antihypertensive Drugs: Angiotensin II Receptor Blockers

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...